Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
378.36
+0.68 (0.18%)
Jul 27, 2026, 4:00 PM EDT - Market closed
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 198,718 | 197,584 | 175,204 | 170,209 | 155,660 | 136,943 | |
Revenue Growth | 5.76% | 12.77% | 2.94% | 9.35% | 13.67% | 13.36% |
Cost of Revenue | 170,701 | 169,401 | 147,317 | 141,623 | 129,677 | 113,466 |
Gross Profit | 28,017 | 28,183 | 27,887 | 28,586 | 25,983 | 23,477 |
Depreciation & Amortization Expenses | 548 | 628 | 580 | 885 | 767 | 441 |
Other Operating Expenses | 22,564 | 20,984 | 20,025 | 20,087 | 17,700 | 15,918 |
Total Operating Expenses | 23,112 | 21,612 | 20,605 | 20,972 | 18,467 | 16,359 |
Operating Income | 4,905 | 6,571 | 7,282 | 7,614 | 7,516 | 7,118 |
Interest Income | 2,587 | 2,194 | 2,051 | 1,825 | 1,485 | 1,378 |
Interest Expense | -1,438 | -1,402 | -1,185 | -1,030 | -851 | -798 |
Other Non-Operating Income (Expense) | -192 | -653 | -244 | -694 | -550 | 297 |
Total Non-Operating Income (Expense) | 957 | 139 | 622 | 101 | 84 | 877 |
Pretax Income | 5,862 | 6,710 | 7,904 | 7,715 | 7,600 | 7,995 |
Provision for Income Taxes | 915 | 1,049 | 1,933 | 1,724 | 1,712 | 1,846 |
Net Income | 4,947 | 5,661 | 5,971 | 5,991 | 5,888 | 6,149 |
Minority Interest in Earnings | -13 | -1 | -9 | 4 | -6 | -9 |
Net Income to Common | 4,963 | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Net Income Growth | -7.41% | -5.32% | -0.12% | 1.58% | -4.29% | 34.69% |
Shares Outstanding (Basic) | 220 | 224 | 232 | 236 | 240 | 244 |
Shares Outstanding (Diluted) | 221 | 225 | 233 | 237 | 243 | 247 |
Shares Change | -3.64% | -3.56% | -1.90% | -2.22% | -1.62% | -2.95% |
EPS (Basic) | 22.56 | 25.28 | 25.81 | 25.38 | 24.56 | 25.26 |
EPS (Diluted) | 22.50 | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 |
EPS Growth | -4.25% | -1.83% | 1.82% | 3.87% | -2.69% | 38.77% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 6,289 | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Growth | 17.84% | -30.27% | -32.71% | -6.65% | -0.41% | -24.72% |
Free Cash Flow Per Share | 28.46 | 14.13 | 19.54 | 28.50 | 29.85 | 29.49 |
Dividends Per Share | 6.860 | 6.840 | 6.520 | 5.920 | 5.120 | 4.520 |
Dividend Growth | 2.70% | 4.91% | 10.13% | 15.63% | 13.27% | 18.95% |
Gross Margin | 14.10% | 14.26% | 15.92% | 16.79% | 16.69% | 17.14% |
Operating Margin | 2.47% | 3.33% | 4.16% | 4.47% | 4.83% | 5.20% |
Profit Margin | 2.49% | 2.87% | 3.41% | 3.52% | 3.78% | 4.49% |
FCF Margin | 3.16% | 1.61% | 2.60% | 3.97% | 4.66% | 5.31% |
EBITDA | 6,617 | 8,316 | 8,828 | 9,007 | 9,191 | 8,420 |
EBITDA Margin | 3.33% | 4.21% | 5.04% | 5.29% | 5.90% | 6.15% |
EBIT | 4,905 | 6,571 | 7,282 | 7,614 | 7,516 | 7,118 |
EBIT Margin | 2.47% | 3.33% | 4.16% | 4.47% | 4.83% | 5.20% |
Effective Tax Rate | 15.61% | 15.63% | 24.46% | 22.35% | 22.53% | 23.09% |